{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:20:50Z","timestamp":1790076050040,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Robert Koch Institute"},{"name":"German Federal Ministry of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijid.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T16:16:06Z","timestamp":1509466566000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities"],"prefix":"10.1016","volume":"66","author":[{"given":"J.M.","family":"Haussig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gassowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bannert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.T.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-2692","authenticated-orcid":false,"given":"R.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2017.10.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097759","article-title":"Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman","author":"Al Baqlani","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S0950268811000148","article-title":"Investigation of a large community-based outbreak of hepatitis B infection in the United Kingdom","volume":"140","author":"Andersson","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"3 Suppl. 1","key":"10.1016\/j.ijid.2017.10.008_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2002-32760","article-title":"Die Hepatitiden B und C bei drogenabh\u00e4ngigen Patienten: Eine epidemiologische Studie","volume":"2002","author":"Brack","year":"2002","journal-title":"Suchttherapie"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/INF.0b013e3181ef22d5","article-title":"Hepatitis B virus infections among children and adolescents in Germany: migration background as a risk factor in a low seroprevalence population","volume":"30","author":"Cai","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2017.10.008_bib0025","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.drugalcdep.2006.09.022","article-title":"Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users","volume":"91","author":"Campbell","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1386-6532(01)00175-5","article-title":"Outbreak of hepatitis B among injecting drug users in Denmark","volume":"22","author":"Christensen","year":"2001","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.ijid.2017.10.008_bib0035","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1055\/s-0031-1273462","article-title":"[Prophylaxis: diagnosis and therapy of hepatitis B virus infection \u2014 the German guideline]","volume":"49","author":"Cornberg","year":"2011","journal-title":"Z Gastroenterol"},{"issue":"1\u20132","key":"10.1016\/j.ijid.2017.10.008_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2009.11.013","article-title":"Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status","volume":"108","author":"Day","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.008_bib0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/pubmed\/22.4.531","article-title":"Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England","volume":"22","author":"Edeh","year":"2000","journal-title":"J Public Health Med"},{"key":"10.1016\/j.ijid.2017.10.008_bib0050","series-title":"ECDC and EMCDDA guidance","article-title":"Prevention and control of infectious diseases among people who inject drugs","author":"European Centre for Disease Prevention and Control","year":"2011"},{"key":"10.1016\/j.ijid.2017.10.008_bib0055","series-title":"Systematic review on hepatitis B and C prevalence in the EU\/EEA","author":"European Centre for Disease Prevention and Control","year":"2016"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amepre.2008.03.028","article-title":"Economic evaluation of delivering hepatitis B vaccine to injection drug users","volume":"35","author":"Hu","year":"2008","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ijid.2017.10.008_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.02.072","article-title":"Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis","author":"Kamath","year":"2014","journal-title":"Vaccine"},{"issue":"09","key":"10.1016\/j.ijid.2017.10.008_bib0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1055\/s-0029-1245304","article-title":"Wissensstand, Pr\u00e4ventionsverhalten und Therapieadh\u00e4renz von Patienten mit chronischer Hepatitis B in einem gro\u00dfen terti\u00e4ren Zentrum in Deutschland","volume":"48","author":"Lutgehetmann","year":"2010","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"issue":"9791","key":"10.1016\/j.ijid.2017.10.008_bib0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41124-016-0016-6","article-title":"Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany","volume":"1","author":"Nielsen","year":"2016","journal-title":"Hepatol Med Policy"},{"issue":"5\u20136","key":"10.1016\/j.ijid.2017.10.008_bib0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00103-013-1673-x","article-title":"[Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]","volume":"56","author":"Poethko-M\u00fcller","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"15","key":"10.1016\/j.ijid.2017.10.008_bib0090","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.vaccine.2005.12.045","article-title":"Hepatitis vaccination among drug users","volume":"24","author":"Quaglio","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1471-2458-11-351","article-title":"A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations","volume":"11","author":"Removille","year":"2011","journal-title":"BMC Public Health"},{"issue":"43","key":"10.1016\/j.ijid.2017.10.008_bib0100","first-page":"2893","article-title":"Hepatitisimpfung auf offenen Drogenszenen","volume":"101","author":"Ridder","year":"2004","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ijid.2017.10.008_bib0105","first-page":"305","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: August 2014","volume":"34","author":"Robert Koch-Institut (RKI)","year":"2014","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.ijid.2017.10.008_bib0110","series-title":"Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2015","author":"Robert Koch-Institut (RKI)","year":"2016"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1743-422X-10-72","article-title":"Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots-performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification","volume":"10","author":"Ross","year":"2013","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.ijid.2017.10.008_bib0120","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.2105\/AJPH.2014.302487","article-title":"Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users","volume":"105","author":"Shah","year":"2015","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.ijid.2017.10.008_bib0125","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","article-title":"History of syringe sharing in prison and risk of hepatitis B virus: hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin","volume":"26","author":"Stark","year":"1997","journal-title":"Int J Epidemiol"},{"issue":"13","key":"10.1016\/j.ijid.2017.10.008_bib0130","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.vaccine.2005.11.055","article-title":"Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales","volume":"24","author":"Sutton","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.008_bib0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.12846","article-title":"Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis","volume":"110","author":"Tavitian-Exley","year":"2015","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.ijid.2017.10.008_bib0140","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1465-3362.2009.00060.x","article-title":"Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review","volume":"28","author":"Topp","year":"2009","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.ijid.2017.10.008_bib0145","series-title":"World Drug Report 2014 in United Nations publication, Sales No. E.14. XI.7","author":"United Nations Office on Drugs and Crime","year":"2014"},{"issue":"0","key":"10.1016\/j.ijid.2017.10.008_bib0150","article-title":"Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial","author":"Weaver","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2017.10.008_bib0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2431-9-18","article-title":"Identification and characteristics of vaccine refusers","volume":"9","author":"Wei","year":"2009","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-3545-4","article-title":"High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011\u201314)","volume":"16","author":"Wenz","year":"2016","journal-title":"BMC Public Health"},{"issue":"40","key":"10.1016\/j.ijid.2017.10.008_bib0165","first-page":"405","article-title":"Hepatitis B vaccines","volume":"84","author":"World Health Organisation (WHO)","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2017.10.008_bib0170","series-title":"Guidance on prevention of viral hepatitis B and C among people who inject drugs","author":"World Health Organization","year":"2012"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.008_bib0175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1186\/1471-2458-14-845","article-title":"A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling","volume":"14","author":"Zimmermann","year":"2014","journal-title":"BMC Public Health"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217302643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217302643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:38:13Z","timestamp":1761118693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217302643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"alternative-id":["S1201971217302643"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.10.008","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}